The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor

Prostate cancer that recurs following androgen-deprivation therapy is termed castration-resistant, which is incurable and is marked by reactivation of androgen receptor (AR) signaling. KIF20A, a kinesin with unique structural features, is overexpressed in human castration-resistant prostate cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Copello, Valeria A., Burnstein, Kerry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107495/
https://www.ncbi.nlm.nih.gov/pubmed/35418689
http://dx.doi.org/10.1038/s41388-022-02307-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107495/
https://www.ncbi.nlm.nih.gov/pubmed/35418689
http://dx.doi.org/10.1038/s41388-022-02307-9

Ejemplares similares